ODI Pharma AB

ODI Pharma is a producer and supplier of medical cannabis products. The business is run through subsidiaries and partners where sales are made through wholesale distributors and pharmacies. The products are used for the treatment of, for example, multiple sclerosis, chronic pain and chemotherapy. Operations are found within the European market, with the headquarters in Stockholm.

Quotes for ODI Pharma AB

Board

CEO

  • Jan-Mark Edewaard

Chairperson of the Board

  • Volker Wiederrich

Board

  • Gösta Lidén
  • Jan-Mark Edewaard
  • Karina Kilinski
  • Malcolm Allan
Articles of association

Videos

1 / 1
CompanyPresentation ODI Pharma AB - Company presentation
** Powered by Modular Finance
*Powered by Modular Finance
Key Numbers
2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-06-30 2025-03-31 2024-12-31
Number of months that the report spans Q3 3 Months Q2 3 Months Q1 3 Months 2025 Q4 3 Months Q3 3 Months Q2 3 Months
Total revenue MSEK 12.71 10.93 5.97 3.11 0.01 2.93 0.00
Earnings before interest and tax MSEK 0.31 1.49 0.11 -5.24 -1.52 -0.22 -2.32
Profit before tax MSEK 0.13 1.30 -0.04 -5.87 -1.66 -0.34 -2.56
Net profit MSEK 0.13 1.30 -0.04 -5.88 -1.67 -0.34 -2.56
Earnings per share SEK 0.01 0.07 0.00 -0.32 -0.09 -0.02 -0.16
Dividend per share SEK 0,00 0,00 0,00 0.00 0,00 0,00 0,00
Equity MSEK 1.79 1.93 0.29 0.81 0.81 0.84 0.45
Fixed assets MSEK 0.01 0.01 0.00 0.00 0.00 0.01 0.01
Intangible assets MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current assets MSEK 10.51 9.92 7.39 5.75 5.75 7.37 6.62
Total asset MSEK 10.53 9.93 7.39 5.76 5.76 7.38 6.63
Long term liabilities MSEK 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities MSEK 8.74 8.00 7.10 4.94 4.94 6.53 6.18
Number of shares SEK 18348419.00 18348419.00 18330419.00 18348419.00 18348419.00 15915034.00 15915034.00
*Compiled data from Millistream